share_log

Demystifying Astrana Health: Insights From 3 Analyst Reviews

Benzinga ·  Nov 13 23:01

3 analysts have expressed a variety of opinions on Astrana Health (NASDAQ:ASTH) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings21000
Last 30D01000
1M Ago10000
2M Ago10000
3M Ago00000

Analysts have set 12-month price targets for Astrana Health, revealing an average target of $74.0, a high estimate of $86.00, and a low estimate of $66.00. Witnessing a positive shift, the current average has risen by 16.54% from the previous average price target of $63.50.

bigjpg

Analyzing Analyst Ratings: A Detailed Breakdown

The standing...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment